These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3280157)

  • 1. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study.
    Brevetti G; Chiariello M; Ferulano G; Policicchio A; Nevola E; Rossini A; Attisano T; Ambrosio G; Siliprandi N; Angelini C
    Circulation; 1988 Apr; 77(4):767-73. PubMed ID: 3280157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-carnitine on the reactive hyperemia in patients affected by peripheral vascular disease: a double-blind, crossover study.
    Brevetti G; Attisano T; Perna S; Rossini A; Policicchio A; Corsi M
    Angiology; 1989 Oct; 40(10):857-62. PubMed ID: 2679240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review to evaluate the effectiveness of carnitine supplementation in improving walking performance among individuals with intermittent claudication.
    Delaney CL; Spark JI; Thomas J; Wong YT; Chan LT; Miller MD
    Atherosclerosis; 2013 Jul; 229(1):1-9. PubMed ID: 23557982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study.
    Brevetti G; Perna S; Sabbà C; Rossini A; Scotto di Uccio V; Berardi E; Godi L
    Eur Heart J; 1992 Feb; 13(2):251-5. PubMed ID: 1555624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The walking-through phenomenon in arterial occlusive disease].
    Maass U; Goller B; Grothe R; Schneider B
    Vasa; 1995; 24(3):233-7. PubMed ID: 7676731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trial.
    Goldenberg NA; Krantz MJ; Hiatt WR
    Vasc Med; 2012 Jun; 17(3):145-54. PubMed ID: 22615190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European multicenter study on propionyl-L-carnitine in intermittent claudication.
    Brevetti G; Diehm C; Lambert D
    J Am Coll Cardiol; 1999 Nov; 34(5):1618-24. PubMed ID: 10551714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
    Brevetti G; Perna S; Sabbá C; Martone VD; Condorelli M
    J Am Coll Cardiol; 1995 Nov; 26(6):1411-6. PubMed ID: 7594063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial.
    Arosio E; De Marchi S; Zannoni M; Prior M; Lechi A
    Mayo Clin Proc; 2002 Aug; 77(8):754-9. PubMed ID: 12173710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interval exercise in arterial occlusive disease].
    Maass U; Goller B; Grote R; Alexander K
    Vasa; 1989; 18(3):209-14. PubMed ID: 2800681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treadmill exercise on blood gases and acid-base balance in patients with intermittent claudication.
    Maass U; Alexander K
    Z Kardiol; 1983 Sep; 72(9):537-42. PubMed ID: 6415947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
    Dal Lago A; De Martini D; Flore R; Gaetani E; Gasbarrini A; Gerardino L; Pola R; Santoliquido A; Serricchio M; Tondi P; Nolfe G
    Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of exercise conditioning for patients with peripheral arterial disease.
    Hiatt WR; Regensteiner JG; Hargarten ME; Wolfel EE; Brass EP
    Circulation; 1990 Feb; 81(2):602-9. PubMed ID: 2404633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication.
    Hiatt WR; Regensteiner JG; Creager MA; Hirsch AT; Cooke JP; Olin JW; Gorbunov GN; Isner J; Lukjanov YV; Tsitsiashvili MS; Zabelskaya TF; Amato A
    Am J Med; 2001 Jun; 110(8):616-22. PubMed ID: 11382369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine-related alterations in patients with intermittent claudication: indication for a focused carnitine therapy.
    Brevetti G; di Lisa F; Perna S; Menabó R; Barbato R; Martone VD; Siliprandi N
    Circulation; 1996 May; 93(9):1685-9. PubMed ID: 8653874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease.
    Hiatt WR; Wolfel EE; Regensteiner JG; Brass EP
    J Appl Physiol (1985); 1992 Jul; 73(1):346-53. PubMed ID: 1506390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of propionyl-L-carnitine on quality of life in intermittent claudication.
    Brevetti G; Perna S; Sabba C; Martone VD; Di Iorio A; Barletta G
    Am J Cardiol; 1997 Mar; 79(6):777-80. PubMed ID: 9070558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.
    Brass EP; Koster D; Hiatt WR; Amato A
    Vasc Med; 2013 Feb; 18(1):3-12. PubMed ID: 23321261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of naftidrofuryl in patients with intermittent claudication.
    Karnik R; Valentin A; Stöllberger C; Slany J
    Angiology; 1988 Mar; 39(3 Pt 1):234-40. PubMed ID: 3281516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design.
    Fabry R; Monnet P; Schmidt J; Lusson JR; Carpentier PH; Baguet JC; Dubray C
    Vasa; 2009 Aug; 38(3):213-24. PubMed ID: 19736632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.